209 studies found for:
"Herpes Zoster" [DISEASE]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
|
||||
| 22 | Not yet recruiting |
A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
|
||||
| 23 | Active, not recruiting |
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years
|
||||
| 24 | Unknown † |
Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand
|
||||
| 25 | Approved for marketing |
Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
|
||||
| 26 | Completed |
Evolution of Pain From Herpes Zoster
|
||||
| 27 | Completed |
Shingles: Immune Effects of Tai Chi
|
||||
| 28 | Completed |
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
|
||||
| 29 | Completed |
Month 30 & 42 Extension Studies of CRD-004 Primary Study
|
||||
| 30 | Recruiting |
Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain
|
||||
| 31 |
Completed
Has Results |
Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
|
||||
| 32 | Active, not recruiting |
Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects
|
||||
| 33 | Completed |
A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013)
|
||||
| 34 | Recruiting |
Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
|
||||
| 35 | Active, not recruiting |
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
|
||||
| 36 | Active, not recruiting |
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years
|
||||
| 37 | Completed |
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
|
||||
| 38 | Active, not recruiting |
Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older
|
||||
| 39 | Recruiting |
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
|
||||
| 40 | Recruiting |
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
|
† Indicates status has not been verified in more than two years

